Search Within

Eileen O'Reilly

Formats
  1. Meeting Abstract (370)
  2. Journal Article (365)
  3. Review (24)
  4. Book Section (9)
  5. Correspondence (9)
  6. Editorial (8)
  7. Conference Paper (5)
  8. Miscellaneous (5)
  9. Book Whole (4)
  10. Guidelines (3)
  11. Research Letter (1)
Groups
  1. Center for Pancreatic Cancer Research (803)
  2. Department of Medicine (803)
  3. Gastrointestinal Oncology Service (803)
  4. Solid Tumor Oncology Division (803)
  5. Epidemiology and Biostatistics (184)
  6. Surgery (173)

More Groups

People
  1. Ghassan Abou-Alfa (160)
  2. Kenneth Yu (123)
  3. David Kelsen (112)
  4. Maeve Lowery (99)
  5. Marinela Capanu (97)
  6. William Jarnagin (88)

More People

Years
  1. 2025 (50)
  2. 2024 (76)
  3. 2023 (73)
  4. 2022 (57)
  5. 2021 (54)
  6. 2020 (70)

More Years

Publications
  1. Journal of Clinical Oncology (296)
  2. Annals of Oncology (51)
  3. Cancer (28)
  4. Annals of Surgical Oncology (26)
  5. Clinical Cancer Research (23)
  6. Gastrointestinal Cancer Research (18)

More Publications

Publishers
  1. American Society of Clinical Oncology (312)
  2. Oxford University Press (75)
  3. Elsevier Inc. (49)
  4. Springer (47)
  5. Wiley Blackwell (43)
  6. American Association for Cancer Research (40)

More Publishers

Results (803)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Helping patients understand pancreatic cancer using animated pancreas patient education with visual formats of learning
    Journal Article

    Munigala, S.; Gardner, T. B.; O'Reilly, E. M.; Fernández-Del Castillo, C.; Ko, A. H.; Pleskow, D.; Vollmer, C. M. Jr; Searle, N. A.; Bakelman, D.; Holt, J. M.; more...
    Pancreas (2022)

    Fulltext@MSK | Save
  • Efficacy of preoperative mFOLFIRINOX vs mFOLFIRINOX plus hypofractionated radiotherapy for borderline resectable adenocarcinoma of the pancreas: The A021501 phase 2 randomized clinical trial
    Journal Article

    Katz, M. H. G.; Shi, Q.; Meyers, J.; Herman, J. M.; Chuong, M.; Wolpin, B. M.; Ahmad, S.; Marsh, R.; Schwartz, L.; Behr, S.; more...
    JAMA Oncology (2022)

    Fulltext@MSK | Save
  • Radiation therapy (RT) quality assurance (QA) analysis of Alliance A021501: Preoperative mFOLFIRINOX or mFOLFIRINOX plus hypofractionated radiation therapy for borderline resectable adenocarcinoma of the pancreas (PDAC)
    Meeting Abstract

    Tchelebi, L.; Smith, K. S.; Shi, Q.; Fitzgerald, T.; Chuong, M. D.; Zemla, T.; O'Reilly, E.; Meyerhardt, J.; Koay, E. J.; Leif, J. L.; more...
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save
  • Multi-institutional comparison of ablative radiation therapy in 5 versus 15-25 fractions for locally advanced pancreatic cancer
    Meeting Abstract

    Reyngold, M.; O'Reilly, E.; Herrera, R.; Kaiser, A.; Zinovoy, M.; Romesser, P. B.; Wu, A. J.; Hajj, C.; Cuaron, J.; Ucar, A.; more...
    International Journal of Radiation Oncology, Biology, Physics (2022)

    Fulltext@MSK | Save
  • Precision medicine and immunotherapy in GI cancers
    Editorial

    O'Reilly, E. M.; Ko, A. H.
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Phase III study (daNIS-2) of the antieTGF-β monoclonal antibody NIS793 with nab-paclitaxel/gemcitabine vs nab-paclitaxel/gemcitabine alone in patients with first-line metastatic pancreatic ductal adenocarcinoma
    Meeting Abstract

    O'Reilly, E.; Golan, T.; Ikeda, M.; Milella, M.; Taieb, J.; Wainberg, Z.; Wang, L.; Gyambibi, N.; López, E.; Xu, K.; more...
    Annals of Oncology (2022)

    Fulltext@MSK | Save
  • Comprehensive assessment of germline pathogenic variant detection in tumor-only sequencing
    Journal Article

    Terraf, P.; Pareja, F.; Brown, D. N.; Ceyhan-Birsoy, O.; Misyura, M.; Rana, S.; O'Reilly, E.; Carlo, M. I.; Aghajanian, C.; Liu, Y.; more...
    Annals of Oncology (2022)

    Fulltext@MSK | Save
  • Circulating tumor and invasive cell expression profiling predicts effective therapy in pancreatic cancer
    Journal Article

    Yu, K. H.; Park, J.; Mittal, A.; Abou-Alfa, G. K.; El Dika, I.; Epstein, A. S.; Ilson, D. H.; Kelsen, D. P.; Ku, G. Y.; Li, J.; more...
    Cancer (2022)

    Fulltext@MSK | Save
  • Sotigalimab and/or nivolumab with chemotherapy in first-line metastatic pancreatic cancer: Clinical and immunologic analyses from the randomized phase 2 PRINCE trial
    Journal Article

    Padrón, L. J.; Maurer, D. M.; O’Hara, M. H.; O’Reilly, E. M.; Wolff, R. A.; Wainberg, Z. A.; Ko, A. H.; Fisher, G.; Rahma, O.; Lyman, J. P.; more...
    Nature Medicine (2022)

    Fulltext@MSK | Save
  • Neoadjuvant radiotherapy after (m)FOLFIRINOX for borderline resectable pancreatic adenocarcinoma: A TAPS Consortium study
    Journal Article

    Janssen, Q. P.; van Dam, J. L.; Prakash, L. R.; Doppenberg, D.; Crane, C. H.; van Eijck, C. H. J.; Ellsworth, S. G.; Jarnagin, W. R.; O'Reilly, E. M.; Paniccia, A.; more...
    Journal of the National Comprehensive Cancer Network (2022)

    Fulltext@MSK | Save